131 related articles for article (PubMed ID: 9399352)
1. Maternal serum alpha-fetoprotein and human chorionic gonadotropin in pregnant women with acute parvovirus B19 infection with and without fetal complications.
Komischke K; Searle K; Enders G
Prenat Diagn; 1997 Nov; 17(11):1039-46. PubMed ID: 9399352
[TBL] [Abstract][Full Text] [Related]
2. Maternal serum testing for alpha-fetoprotein and human chorionic gonadotropin in high-risk pregnancies.
Jauniaux E; Gulbis B; Tunkel S; Ramsay B; Campbell S; Meuris S
Prenat Diagn; 1996 Dec; 16(12):1129-35. PubMed ID: 8994249
[TBL] [Abstract][Full Text] [Related]
3. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome.
Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ
J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623
[TBL] [Abstract][Full Text] [Related]
4. Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases.
Enders M; Weidner A; Zoellner I; Searle K; Enders G
Prenat Diagn; 2004 Jul; 24(7):513-8. PubMed ID: 15300741
[TBL] [Abstract][Full Text] [Related]
5. [The relationship between maternal infection with human parvovirus B19 and fetal death and congenital malformation].
Li B; Qu X; Wang S
Zhonghua Fu Chan Ke Za Zhi; 2001 Jan; 36(1):24-6. PubMed ID: 11778539
[TBL] [Abstract][Full Text] [Related]
6. Elevated second trimester maternal serum beta-HCG concentrations and subsequent adverse pregnancy outcome.
Gravett CP; Buckmaster JG; Watson PT; Gravett MG
Am J Med Genet; 1992 Nov; 44(4):485-6. PubMed ID: 1279970
[TBL] [Abstract][Full Text] [Related]
7. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
Benn PA
Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
[TBL] [Abstract][Full Text] [Related]
8. Second-trimester maternal serum alpha-fetoprotein and human chorionic gonadotrophin screening for Down's syndrome in Hong Kong.
Lam YH; Ghosh A; Tang MH; Tang LC; Lee CP; Sin SY; Ho PK
Prenat Diagn; 1998 Jun; 18(6):585-89. PubMed ID: 9664604
[TBL] [Abstract][Full Text] [Related]
9. Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome.
Spencer K
Prenat Diagn; 2000 Aug; 20(8):652-6. PubMed ID: 10951476
[TBL] [Abstract][Full Text] [Related]
10. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG
Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738
[TBL] [Abstract][Full Text] [Related]
11. [Human parvovirus B19 infection in perinatal transmission and abnormal fetuses].
Zhong M; Cao H; Wen S
Zhonghua Fu Chan Ke Za Zhi; 1997 Apr; 32(4):205-7. PubMed ID: 9596898
[TBL] [Abstract][Full Text] [Related]
12. Outcome of pregnancies with elevation of both maternal serum alpha-fetoprotein and human chorionic gonadotropin.
Kuller JA; Sellati LE; Chescheir NC; Helwick JJ; Lincoln-Boyea B; Boor-Smith C; McCoy MC; Katz VL
Am J Perinatol; 1995 Mar; 12(2):93-7. PubMed ID: 7540011
[TBL] [Abstract][Full Text] [Related]
13. Lack of association between unexplained elevated maternal serum alpha fetoprotein and/or human chorionic gonadotropin and the occurrence of placental thrombotic lesions.
Salim R; Okopnik M; Garmi G; Nachum Z; Zafran N; Shalev E
Placenta; 2010 Apr; 31(4):277-81. PubMed ID: 20132984
[TBL] [Abstract][Full Text] [Related]
14. Uterine malformation: a cause of elevated maternal serum alpha-fetoprotein concentrations.
Heinonen S; Ryynänen M; Kirkinen P; Saarikoski S
Prenat Diagn; 1996 Jul; 16(7):635-9. PubMed ID: 8843473
[TBL] [Abstract][Full Text] [Related]
15. [Dependence of the concentration of maternal serum markers on the haptoglobin gene].
Chivilev IV; Zolotukhina TV; Spitsyn VA; Nurbaev SD; Gribkova LG
Genetika; 1997 Mar; 33(3):399-404. PubMed ID: 9244773
[TBL] [Abstract][Full Text] [Related]
16. Biochemical screening for chromosomal disorders and neural tube defects (NTD): is adjustment of maternal alpha-fetoprotein (AFP) still appropriate in insulin-dependent diabetes mellitus (IDDM)?
Sancken U; Bartels I
Prenat Diagn; 2001 May; 21(5):383-6. PubMed ID: 11360279
[TBL] [Abstract][Full Text] [Related]
17. Parvovirus B19 infection in pregnancy: quantitative viral DNA analysis using a kinetic fluorescence detection system (TaqMan PCR).
Knöll A; Louwen F; Kochanowski B; Plentz A; Stüssel J; Beckenlehner K; Jilg W; Modrow S
J Med Virol; 2002 Jun; 67(2):259-66. PubMed ID: 11992588
[TBL] [Abstract][Full Text] [Related]
18. Maternal serum human chorionic gonadotropin as a marker for the delivery of low-birth-weight infants in women with unexplained elevations in maternal serum alpha-fetoprotein.
Hurley TJ; Miller C; O'Brien TJ; Blacklaw M; Quirk JG
J Matern Fetal Med; 1996; 5(6):340-4. PubMed ID: 8972411
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence, incidence of prenatal infections and reliability of maternal history of varicella zoster virus, cytomegalovirus, herpes simplex virus and parvovirus B19 infection in South-Western Finland.
Alanen A; Kahala K; Vahlberg T; Koskela P; Vainionpää R
BJOG; 2005 Jan; 112(1):50-6. PubMed ID: 15663397
[TBL] [Abstract][Full Text] [Related]
20. Maternal-fetal transmission of human parvovirus B19 genotype 3.
Candotti D; Danso K; Parsyan A; Dompreh A; Allain JP
J Infect Dis; 2006 Sep; 194(5):608-11. PubMed ID: 16897659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
